REN and metabolic dysfunction-associated steatotic liver disease: In NAFLD (non-alcoholic fatty liver disease), patients that develop cirrhosis experience an increase of cardiac output and central blood volume leading to increased activity in both the SNS (sympathetic nerve system) and RAAS (renin–angiotensin–aldosterone system), and thereby hyperdynamic circulation.